MedPath

Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief

Not Applicable
Conditions
Postoperative Complications
Interventions
Registration Number
NCT02976571
Lead Sponsor
Wolfson Medical Center
Brief Summary

A comparison between local and intraperitoneal analgetics to placebo, during laparoscopy, regarding post operative pain.

Detailed Description

4 randomly assigned groups. Grop 1 will get sub cutaneous and intraperitoneal marcain. Grop 2 will get sub cutaneous marcaine and intraperitoneal saline. Grop 3 will get sub cutaneus saline and intraperitoneal marcaine. Grop 4 will get ub cutaneous and intraperitoneal saline

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Elective laparoscopy
Exclusion Criteria
  • Laparotomy Vaginal operations Oncologic operations Chronic use of analgetics due to pelvic pain Pregnancy Operations lasts more than 3 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sub cutaneous+IntraperitonealBupivacaineSub cutaneous Bupivacaine+ Intraperitoneal bupivacaine
Sub cutaneous+PlaceboBupivacaineSub cutaneous Bupivacaine+ Intraperitoneal Nacl 0.9%
Placebo+IntraperitonealBupivacaineSub cutaneous Nacl 0.9%+ Intraperitoneal bupivacaine
Placebo+PlaceboBupivacaineSub cutaneous Nacl 0.9%+ Intraperitoneal Nacl 0.9%
Primary Outcome Measures
NameTimeMethod
Pain level during movement, 8 hours after laparoscopy8 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wolfson medical center

🇮🇱

H̱olon, Israel

© Copyright 2025. All Rights Reserved by MedPath